Surfactant in Pediatric Respiratory Failure

Von Neergaard K. Neue affasungen uber einen grudnbegriff atemmedranik. Die retraktionskraft der lunge, abhangig von der oberfachen spannung en den alveolen. Z. Die Gasamte Exp Med 1929;66:373–394.

Hills BA . The biology of surfactant. Cambridge, UK: Cambridge University Press, 1988:3.

Macklin CC . The pulmonary alveolar mucoid film and pneumocytes. Lancet 1954;i:1099–1104.

Pattle RE . Properties, function, and origin of the alveolar lining layer. Nature 1955;175:1125–1126.

Clements JA . Surface tension of lung extracts. Proc Soc Exp Biol Med 1957;95:170–172.

Avery ME , Mead J. Surface properties in relation to atelectasis in hyaline membrane disease. Am J Dis Child 1959;97:517–523.

Fujiwara T , Maeta H , Chida S , Watabe Y , Abe T. Artificial surfactant therapy in hyaline membrane diseases. Lancet 1980;1(8159):55–59.

Wegman ME . Annual summary of vital statistics—1990. Pediatrics 1991;88(6):1081–1092.

Hills BA . The biology of surfactant. Cambridge, UK: Cambridge University Press, 1988:10.

Holm BA , Matalon S. Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome (review). Anesth Analg 1989;69(6):805–818.

Rooney SA . The surfactant system and lung phospholipid biochemistry (review). Am Rev Respir Dis 1985;131(3):439–460.

Hawgood S. Surfactant: composition, structure, and metabolism. In: The lung, scientific foundations. 2nd edition. Crystal RG and West JB , et al, editors. Philadelphia: Lippincott-Raven, 1997:560.

White RT , Damm D , Miller J , Spratt K , Schilling J , Hawgood S. , et al. Isolation and characterization of the human pulmonary surfactant apoprotein gene. Nature 1985;317(6035):361–363.

Whitsett JA , Ohning BL , Ross G , Meuth J , Weaver T , Holm BA , et al. Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy. Pediatr Res 1986;20(5):460–467.

Chung J , Yu SH , Whitsett JA , Harding PG , Possmayer F. Effect of surfactant-associated protein-A (SP-A) on the activity of lipid extract surfactant. Biochim Biophys Acta 1989;1002(3):348–358.

Haagsman HP , Hawgood S , Sargeant T , Buckley D , White RT , Drickhamer K , Benson BJ . The major surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. J Biol Chem 1987;262(29):13877–13880.

Voss T , Eistetter H , Schafer KP , Engel J. Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36: structural homology with the complement factor C1q. J Mol Biol 1988;201(1):219–227.

Crouch E , Persson A , Chang D , Heuser J. Molecular structure of pulmonary surfactant protein D (SP-D). J Biol Chem 1994;269(25):17311–17319.

Poulain FR , Allen L , Williams MC , Hamilton RL , Hawgood S. Effects of surfactant apolipoproteins on liposome structure: implications for tubular myelin formation. Am J Physiol 1992;262(6 Pt 1):L730–L739.

Batenburg JJ . Biosynthesis, secretion, and recycling of surfactant components. In: Robertson B and Taeusch HW , editors. Surfactant therapy for lung disease. New York: Marcel Dekker, 1995:49.

Wright JR , Clements JA . Metabolism and turnover of lung surfactant (review). Am Rev Respir Dis 1987;136(2):426–444.

Kuroki Y , Akino T. Pulmonary surfactant protein A (SP-A) specifically binds dipalmitoylphosphatidylcholine. J Biol Chem 1991;266(5):3068–3073.

Hawgood S , Shiffer K. Structures and properties of surfactant-associated proteins (review). Annu Rev Physiol 1991;53:375–394.

Hawgood S. Surfactant: composition, structure, and metabolism. In: The lung, scientific foundations, 2nd edition. Crystal RG and West JB , et al, editors. Philadelphia: Lippincott-Raven, 1997:562.

Haagsman HP , van Golde LM . Synthesis and assembly of lung surfactant (review). Annu Rev Physiol 1991;53:441–464.

Williams MC . Conversion of lamellar body membranes into tubular myelin in alveoli of fetal rat lungs. J Cell Biol 1977;72(2):260–277.

Suzuki Y , Fujita Y , Kogishi K. Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am Rev Respir Dis 1989;140(1):75–81.

Clements JA . Composition and properties of pulmonary surfactant. In: Respiratory distress syndrome. Villee CA , Villee DB , Zucker-man J , editors. New York: Academic Press, 1973:77–95.

King RJ , MacBeth MC . Interaction of the lipid and protein components of pulmonary surfactant: role of phosphatidylglycerol and calcium. Biochim Biophys Acta 1981;647(2):159–168.

Williams MC . Uptake of lectins by alveolar type II cells: subsequent deposition into lamellar bodies. Proc Natl Acad Sci USA 1984;81(20):6383–6387.

Miles PR , Castranova V , Bowman L. Catabolism of rat surfactant disaturated phosphatidylcholines during incubation of alveolar lavage materials at 37 degrees C. Biochim Biophys Acta 1985;836(1):39–44.

Wirtz HRW , Dobbs LG . Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells. Science 1990;250(4985):1266–1269.

Young LS , Silbajoris RA . Type II cell response to chronic beta adrenergic agonist and antagonist infusions. J Pharmacol Exp Ther 1985;233(1):271–276.

Young SL , Silbajoris RA . Dexamethasone increased adult rat lung surfactant lipids. J Appl Physiol 1986;60:1665–1672.

Hawgood S. Surfactant: composition, structure, and metabolism. In: The lung, scientific foundations, 2nd edition. Crystal RG and West JB , et al, editors. Philadelphia: Lippincott-Raven, 1997:565.

Rice WR , Ross GF , Singleton FM , Dingle S , Whitsett JA . Surfactant-associated protein inhibits phospholipid secretion from type II cells. J Appl Physiol 1987;63:692–698.

Kuroki Y , Mason RJ , Voelker DR . Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells. J Biol Chem 1988;263(7):3388–3394.

Ashbaugh DG , Bigelow DB , Petty TL , Levine BE . Acute respiratory distress syndrome in adults. Lancet 1967;2(7511):319–323.

Petty TL , Ashbaugh DB . The adult respiratory distress syndrome: clinical features, factors influencing prognosis and principles of management. Chest 1971;60(3):233–239.

Petty TL , Reiss OK , Paul GW , Silvers GW , Elkins ND . Characteristics of pulmonary surfactant in adult respiratory distress syndrome associated with trauma and shock. Am Rev Respir Dis 1977;115(3):531–536.

Lewis JF , Jobe AH . Surfactant and the adult respiratory distress syndrome (review). Am Rev Respir Dis 1993;147(1):218–233.

Seeger W , Pison U , Buchhorn R , Obertacke U , Joka T. Surfactant abnormalities and adult respiratory failure. Lung 1990;168 Suppl:891–902.

Gregory TJ , Longmore WJ , Moxley MA , Whitsett JA , Reed CR , Fowler AA 3rd , et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88(6):1976–1981.

Pison U , Obertacke U , Brand M , Seeger W , Joka T , Bruch J , Schmidt-Neuerburg KP . Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J Trauma 1990;30(1):19–26.

Hallman M , Spragg R , Harrell JH , Moser KM , Gluck L. Evidence of lung surfactant abnormality in respiratory failure: study of bronchoalveolar lavage phospholipids, surface activity, and plasma myoinositol. J Clin Invest 1982;70(3):673–683.

Pison U , Seeger W , Buchhorn R , Joka T , Brand M , Obertacke U , et al. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis 1989;140(4):1033–1039.

Young SL , Crapo JP , Kremers SA , Brumley GW . Pulmonary surfactant lipid production in oxygen-exposed rat lungs. Lab Invest 1982;46(6):570–576.

Low RB , Adler KB , Woodcock-Mitchell J , Giancola MS , Vacek PM . Bronchoalveolar lavage lipids during development of bleomycin-induced fibrosis in rats: relationship to altered epithelial cell morphology. Am Rev Respir Dis 1988;138(3):709–713.

Holm BA , Notter RH , Siegle J , Matalon S. Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 1985;59(5):1402–1409.

Pison U , Gono E , Joka T , Obertacke U. Phospholipid lung profile in adult respiratory distress syndrome evidence for surfactant abnormality. Prog Clin Biol Res 1987;236A:517–523.

Ueda T , Ikegami M , Jobe A. Surfactant subtypes: in vitro conversion, in vivo function, and effects of serum proteins. Am J Respir Crit Care Med 1994;149(5):1254–1259.

Yamada T , Ikegami M , Jobe AH . Effects of surfactant subfractions on preterm rabbit lung function. Pediatr Res 1990;27(6):592–598.

Veldhuizen RAW , McCaig LA , Akino T , Lewis JF . Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;152(6 Pt 1):1867–1871.

Gilder H , McSherry CK . Phosphatidylcholine synthesis and pulmonary oxygen toxicity. Biochim Biophys Acta 1976;441(1):48–56.

Holm BA , Matalon S , Finkelstein JN , Notter RH . Type II pneumocyte changes during hyperoxic lung injury and recovery. J Appl Physiol 1988;65(6):2672–2678.

Hall SB , Hyde RW , Notter RH . Changes in subphase aggregates in rabbits injured by free fatty acid. Am J Respir Crit Care Med 1994;149(5):1099–1106.

Huguchi R , Lewis J , Ikegami M. In vitro conversion of surfactant subtypes is altered in alveolar surfactant isolated from injured lungs. Am Rev Respir Dis 1992;145(6):1416–1420.

Seeger W , Gunther A , Walmrath HD , Grimminger F , Lasch HG . Alveolar surfactant and adult respiratory distress syndrome: pathogenic role and therapeutic prospects (review). Clin Investigation; 1993;71(3):177–190.

Holm BA , Notter RH . Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol 1987;63(4):1434–1442.

Holm BA , Notter RH , Finkelstein JN . Surface property changes from interactions of albumen with natural lung surfactant and extracted lung lipids. Chem Phys Lipids 1985;38(3):287–298.

Holm BA , Enhorning G , Notter RH . A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 1988;49(1-2):49–55.

Kobayashi T , Nitta K , Ganzuka M , Inui S , Grossmann G , Robertson B. Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 1991;29(4 Pt 1):353–356.

Holm BA , Matalon S. Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome (review). Anesth Analg 1989;69(6):805–818.

Huang YT , Sane AC , Simonson SG , et al. Artificial surfactant an hyperoxic lung injury in primates: 1. Physiology and biochemistry. J Appl Physiol 1995;78:1816–1822.

Fracica PJ , Caminiti SP , Piantadosi CA , et al. Natural surfactant and hyperoxic lung injury in primates: II. Morphometric analyses. J Appl Physiol 1994;76:1002–1010.

Repine JE , Beehler CJ . Neutrophils and adult respiratory distress syndrome: two interlocking perspectives in 1991 (editorial). Am Rev Respir Dis 1991;144(2):251–252.

Hallman M , Spragg R , Harrell JH , Moser KM , Gluck L. Evidence of lung surfactant abnormality in respiratory failure: study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 1982;70(3):673–683.

Holm BA , Keicher L , Liu MY , Sokolowski J , Enhorning G. Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol 1991;71(1):317–321.

Merritt TA , Hallman M , Spragg R , Heldt GP , Gilliard N. Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome (review). Drugs 1989;38(4):591–611.

Glasser SW , Korthagen TR , Weaver T , Pilot-Matias T , Fox JL ., Whitsett JA . cDNA and deduced amino acid sequence of human pulmonary surfactant-associated proteolipid SPL(Phe). Proc Natl Acad Sci USA 1987;84(12):4007–4011.

Warr RG , Hawgood S , Buckley DI , Crisp TM , Schilling J , Benson BJ ., et al. Low molecular weight human pulmonary surfactant protein (SP5): isolation, characterization, and cDNA and amino acid sequences. Proc Natl Acad Sci USA 1987;84(22):7915–7919.

Halliday HL . Natural vs synthetic surfactants in neonatal respiratory distress syndrome (review). Drugs 1996;51(2):226–237.

Alvarado M , Hingre R , Hakanson D , et al. Clinical trial of Survanta vs Exosurf therapy in infants < 1500g with respiratory distress syndrome (RDS) (abstract). Pediatr Res 1993;33:314.

Horbar JD , Wright LL , Soll RF , Wright EC , Fanaroff AA , Korones SB , et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1993;123(5):757–766.

Modanlou HD , Beharry K , Norris K , et al. Comparative efficacy of Survanta and Exosurf on early clinical course of respiratory distress syndrome (RDS) (abstract). Pediatr Res 1994;35:345.

Modanlou HD , Beharry K , Norris K , et al. Comparative effects of Survanta and Exosurf on the outcome of respiratory distress syndrome (RDS) (abstract). Pediatr Res 1994;35:242.

Pearlman SA , Leef KH , Stefano JL , et al. A randomized trial comparing Exosurf vs. Survanta in the treatment of neonatal RDS (abstract). Pediatr Res 1993;33:340.

Sehgal SS , Ewing CK , Richards T , Taeusch HW . Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study. J Natl Med Assoc 1994;86(1):46–52.

Vermont Oxford Trials Network . A multicenter randomized trial comparing synthetic surfactant to modified bovine surfactant in the treatment of neonatal respiratory distress syndrome (abstract). Pediatr Res 1994;35:259.

Grauaug A , Kohan R , Milner G , et al. Pulmonary function changes using Exosurf or Survanta a randomised trial (abstract). Pediatr Res 1995;37:333.

Hudak ML , Matteson EJ , Baus JA , et al. Infasurf V. Exosurf for the prophylaxis of RDS: a ten center randomized double-masked comparison trial (abstract). Pediatr Res 1994;35:231.

Hudak ML , Matteson EJ , Baus JA , et al. Infasurf V. Exosurf for the treatment of RDS: a 21 center randomized double-masked comparison trial (abstract). Pediatr Res 1994;35:231.

Egan EA , Notter RH , Kwong MS , Shapiro DL . Natural and artificial lung surfactant replacement therapy in premature lambs. J Appl Physiol 1983;55(3):875–883.

Seeger W , Grube C , Gunther A , Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 1993;6(7):971–977.

Cummings JJ , Holm BA , Hudak ML , Hudak BB , Ferguson WH , Egan EA . A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis 1992;145(5):999–1004.

Bloom BT , Delmore P , Kattwinkel J , et al. Randomized double-blind multicenter trial of Survanta and Infasurf (review). Pediatr Res 1994;35:326.

Dreyfuss D , Soler P , Basset G. , Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988;137(5):1159–1164.

Bowton DL , Kong DL . High tidal volume ventilation produces increased lung water in oelic acid-injured rabbit lungs. Crit Care Med 1989;17(9):908–911.

Kolobow T , Moretti MP , Fumagalli R , Mascheroni D , Prato P , Chen V , Joris M. Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation: an experimental study. Am Rev Respir Dis 1987;135(2):312–315.

Nilsson R , Grossmann G , Berggren P , Robertson B. Surfactant treatment in experimental hyaline membrane disease. Eur J Respir Dis 1981;62(6):441–449.

Jobe A , Ikegami M , Glatz T , Yoshida Y , Diakomanolis E , Padbury J. Duration and characteristics of treatment of premature lambs with natural surfactant. J Clin Invest 1981;67(2):370–375.

Kattwinkel J , Bloom BT , Delmore P , Davis CL , Farrell E , Friss H , et al. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks gestation. Pediatrics 1993;92(1):90–98.

Kendig JW , Notter RH , Cox C , Reubens LJ , Davis JM , Maniscalco WM , et al. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks’ gestation. N Engl J Med 1991;324(13):865–871.

Gattinoni L , Pesenti A , Bombino M , Baglioni S , Rivolta M , Rossi F , et al. Relationships between lung computed tomographic density, gas exchange, and PEEP in acute respiratory failure. Anesthesiology 1988;69(6):824–832.

Lewis JF , Tabor B , Ikegami M , Jobe AH , Joseph M , Absolom D. Lung function and surfactant distribution in saline-lavaged sheep given instilled vs nebulized surfactant. J Appl Physiol 1993;74(3):1256–1264.

Lewis JF , Ikegami M , Jobe AH , Absolom D. Physiologic responses and distribution of aerosolized surfactant (Survanta) in a nonuniform pattern of lung injury. Am Rev Respir Dis 1993;147(6 Pt 1):1364–1370.

Lewis J , Ikegami M , Tabor B , Jobe A , Absolom D. Aerosolized surfactant is preferentially deposited in normal versus injured regions of lung in a heterogeneous lung injury model (abstract). Am Rev Respir Dis 1992;145(4 Pt 2):A184.

Anzueto A , Baughman RP , Guntupalli KK , Weg JG , Wiedemann HP , Raventos AA , et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996;334(22):1417–1421.

Willson DF , Jiao JH , Bauman LA , Zaritsky A , Craft H , Dockery K. , et al. Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med 1996;24(8):1316–1322.

Willson DF , Bauman LA , Zaritsky A , et al. Instillation of calf's lung surfactant extract (Infasurf) is beneficial in pediatric acute hypoxemic respiratory failure. Crit Care Med, 1999;27(1):(in press).

Walmrath D , Gunther A , Ghofrani HA , Scermuly R , Schneider T , Grimminger F , Seeger W. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 1996;154(1):57–62.

Berggren P , Lachmann B , Curstedt T , Grossman G , Robertson B. Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage. Acta Anaesthesiol Scand 1986;30(4):321–328.

Matalon S , Egan EA . Effects of 100% O, breathing on permeability of alveolar epithelium to solute. J Appl Physiol 1981;50(4):859–863.

Matalon S , Egan EA . Interstitial fluid volumes and albumin spaces in pulmonary oxygen toxicity. J Appl Physiol 1984;57(6):1767–1772.

Matalon S , Holm BA , Notter RH . Mitigation of pulmonary hyperoxic injury by administration of exogenous surfactant. J Appl Physiol 1987;62(2):756–761.

Ashbaugh DG , Uzawa T. Respiratory and hemodynamic changes after injection of free fatty acids. J Surg Res 1968;8(9):417–423.

Seeger W , Lepper H , Wolf HR , Neuhof RH . Alteration of alveolar surfactant function after exposure to oxidative stress and to oxygenated and native arachidonic acid in vitro. Biochim Biophys Acta 1985;835(1):58–67.

Liau DF , Barrett CR , Bell ALL , Ryan SF . Functional abnormalities of lung surfactant in experimental acute alveolar injury in the dog. Am Rev Respir Dis 1987;136(2):395–401.

Ryan SF , Liau DF , Bell ALL , Hasim SA , Barnett CR . Correlation of lung compliance and quantities of surfactant phospholipids after acute alveolar injury from N-nitroso-N-methylurethane in the dog. Am Rev Respir Dis 1981;123(2):200–204.

Eijking EP , Gommers D , So KL , Vergeer M , Lachmann B. Surfactant treatment of respiratory failure induced by hydrochloric acid aspiration in rats. Anesthesiology 1993;78(6):1145–1151.

Nieman GF , Paskanik AM , Fluck RR , Clark WR . Comparison of exogenous surfactants in the treatment of wood smoke inhalation. Am J Respir Crit Care Med 1995;152(2):597–602.

Van Daal GJ , Bos JAH , Eijking EP , Gommers D , Hannappel E , Lachmann B. Surfactant replacement therapy improves pulmonary mechanics in end-stage influenza A pneumonia in mice. Am Rev Respir Dis 1992;145(4 Pt 1):859–863.

Berry D , Ikegami M , Jobe A. Respiratory distress and surfactant inhibition following vagotomy in rabbits. J Appl Physiol 1986;61(5):1741–1748.

Zelter M , Escudier BJ , Hoeffel JM , Murray JF . Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep. Am Rev Respir Dis 1990;141(4 Pt 1):1014–1019.

Harris JD , Jackson F Jr , Moxley MA , Longmore WJ . Effect of exogenous surfactant instillation on experimental acute lung injury. J Appl Physiol 1989;66(4):1846–1851.

Jobe AH . Pulmonary surfactant therapy (review). N Engl J Med 1993;328(12):861–868.

Hudak ML , Farrell EE , Rosenberg AA , Jung AL , Auten RL , Durand DJ , et al. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome. J Pediatr 1996;128(3):396–406.

Richman PS , Spragg RG , Merritt TA , Robertson B , Curstedt T. Administration of porcine-lung surfactant to humans with ARDS: initial experience (abstract). Am Rev Respir Dis 1987;135(4 Pt. 2):A5.

Lewis J , Dhillon J , Frewen T. Exogenous surfactant therapy in pediatric patients with ARDS (abstract). Am J Respir Crit Care Med 1994;149(4 Pt 2):A125.

Perez-Benavides F , Riff E , Franks C. Adult respiratory distress syndrome and artificial surfactant replacement in the pediatric patient. Pediatr Emerg Care 1995;11(3):153–155.

Nosaka S , Sakai T , Yonekura K , Yoshikawa K. Surfactant for adults with respiratory failure (letter). Lancet 1990;336(8720):947–948.

Gregory TJ , Longmore WJ , Moxely MA , Cai G-Z , Gadek JE , Weiland JE , et al. Surfactant repletion following Survanta supplementation in patients with acute respiratory distress syndrome (ARDS) (abstract). Am J Respir Crit Care Med 1994;149(4 Pt 2):A124.

Spragg RG , Gilliard N , Richman P , Smith RM , Hite RD , Pappert D. , et al. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 1994;105(1):195–202.

Robillard E , Alarie Y , Dagenais-Perusse P , et al. Microaerosol administration of synthetic β-γ-dipalmitoyl-L-α-lecithin in the respiratory distress syndrome: a preliminary report. Can Med Assoc J 1964;90:55–57.

Chu J , Clements JA , Cotton EK , Klaus MH , Sweet AY , Tooley WH , et al. Neonatal pulmonary ischemia. I. Clinical and physiological studies. Pediatrics 1967;40(4. Suppl):709–782.

Horbar JD ., Soll RF ., Sutherland JM ., Kotagal U , Philip AG , Kessler DL ., et al. A multicenter randomized. placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med 1989;320(15):959–965.

Horbar JD , Soll RF , Schachinger H , Kewitz G , Versmold HT , Lindner W , et al. A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome. Eur J Pediatr 1990;149(6):416–423.

Lang MJ , Hall RT , Reddy NS , Kurth CG , Merritt TA . A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants. J Pediatr 1990;116(2):295–300.

Gortner L , Bernsau U , Hellwege HH , Hieronimi G , Jorch G , Reiter HL . A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome. Lung 1990;168 Suppl:864–869.

Chen JY . Exogenous surfactant for treatment of respiratory distress syndrome in premature infants. J Formos Med Assoc 1990;89(2):110–114.

Fujiwara T , Konishi M , Chida S , Okuyama K , Ogawa Y , Takeuchi Y. , et al. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multi-center. double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group. Pediatrics 1990;86(5):753–764.

Corbet A , Bucciarelli R , Goldman S , Mammel M , Wold D , Long W. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1. J Pediatr 1991;118(2):277–284.

Ten Centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group. Br Med J (Clin Res Ed) 1987;294(6578):991–996.

Halliday HL , McClure G , Reid MM , Lappin TR , Meban C , Thomas PS . Controlled trial of artificial surfactant to prevent respiratory distress syndrome. Lancet 1984;1(8375):476–478.

Bose C , Corbet A , Bose G , Garcia-Prats J , Lombardy L , Wold D. , et al. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant. J Pediatr 1990;117(6):947–953.

Wilkinson A , Jenkins PA , Jeffrey JA . Two controlled trials of dry artificial surfactant: early effects and later outcome in babies with surfactant deficiency. Lancet 1985;2(8450):287–291.

Phibbs RH , Ballard RA , Clements JA , Heilbron DC , Phibbs CS , Schlueter MA , et al. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Pediatrics 1991;88(1):1–9.

Stevenson D , Walther F , Long W , Sell M , Pauly T , Gong A , et al. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500-699 grams. The American Exosurf Neonatal Study Group 1. J Pediatr 1992;120(2 Pt 2):S3–S12.

Long W , Thompson T , Sundell H , Schumacher R , Volberg F , Guthrie R. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group 1. J Pediatr 1991;118(4 Pt 1):595–605.

Long W , Corbet A , Cotton R , Courtney S , McGuiness G , Walter D. , et al. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group 1 and the Canadian Exosurf Neonatal Study Group. N Engl J Med 1991;325(24):1696–1703.

Canadian Exosurf . Pediatric Study Group. Effects of two rescue doses of EXOSURF Pediatric in 342 750-1249 gram infants (abstract). Pediatr Res 1990;27:200A.